Inside the rush to develop a coronavirus vaccine04:06
Moderna’s phase one clinical trial data shows all 45 participants developed antibodies that could fight the coronavirus. The vaccine will move into large-scale human trials later this month, enrolling 30,000 participants. When could an effective vaccine be ready for the masses? And will there be enough available? NBC News medical correspondent Dr. John Torres has this week’s Sunday Spotlight.